About Symbio Generrics India Private Limited
Data last updated:
Symbio Generrics India Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 30 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74990KA2011PTC184231. Its GSTIN is 29AAPCS9972B1ZO (Karnataka). The company holds 6 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹3.1 Cr and a paid-up capital of ₹3.01 Cr. It is led by directors including Akash Suresh Puranik (Managing Director) and Salim Sadiq Shaikh (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹434.97 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹4.57 Cr (net margin 1.1%) and EBITDA of ₹29.66 Cr (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 26% over five years.
The company has about 161 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Symbio Generrics. As per MCA filings, the company has open charges of ₹268.03 Cr and satisfied charges of ₹22.92 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 2 cases are pending. The company has 6 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹58.4 Lakh; the latest was in March 2022. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 160 overdue payments to 17 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website symbiogenerics.com.
Company details
CIN history
Symbio Generrics India has one previous CIN (Corporate Identification Number): U74990TN2011PTC080853. The current CIN is U74990KA2011PTC184231, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74990KA2011PTC184231 | Current |
| U74990TN2011PTC080853 | Previous |
Contact details
Symbio Generrics India Private Limited's registered office is in Bangalore, Karnataka. Its website is symbiogenerics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSymbio House No – 1215 24th Main, 11th Cross Hsr Layout 1st Sector, Bangalore, Karnataka, India – 560102
- IndustryPharma, API Manufacturers
To see the full contact details of Symbio Generrics India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Symbio Generrics India operates one associated brand: Symbio Generrics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| CDMO manufacturer of APIs and Intermediates | symbiogenerics.com |
Business activity
The main business activities of Symbio Generrics India are trade and manufacturing. In detail, this covers wholesale trading and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Symbio Generrics India Private Limited, buy the company report.
Financials of Symbio Generrics India Private Limited
FY 2024 filings availableSymbio Generrics India Private Limited reported revenue of ₹434.97 Cr (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.57 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Symbio Generrics India Private Limited, buy the company report.
Board of directors of Symbio Generrics India Private Limited
Symbio Generrics India has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kannan Natraj Sharma Also directs: Renew Akshay Urja Limited, Renserv Global Private Limited | Director | 19 Sep 2022 | 4 Years 1 Months | Current |
| Salim Sadiq Shaikh Also directs: VPL Chemicals Private Limited, Copernicium Pharmaceuticals Private Limited, Sequent Penems Private Limited and 5 more | Whole-Time Director | 30 May 2011 | 15 Years 5 Months | Current |
| Akash Suresh Puranik Also directs: VPL Chemicals Private Limited, Copernicium Pharmaceuticals Private Limited, Sequent Penems Private Limited and 1 more | Managing Director | 30 Sep 2017 | 9 Years 1 Months | Current |
| Deepak Komaregowda Also directs: I-Nurture Education Solutions Private Limited, Naari Pharma Private Limited, Elixa Technologies Private Limited and 2 more | Nominee Director | 30 Mar 2022 | 4 Years 7 Months | Current |
Auditor
Symbio Generrics India Private Limited is audited by K.Kishore & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.Kishore & Co | FY 2023 | 011580S |
Shareholding
The shareholding of Symbio Generrics India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Symbio Generrics India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Nov 2025 | 101189362 | Others | ₹15 Cr | Open | |
| 27 Jun 2024 | 100953388 | Others | ₹12 Cr | Open | |
| 14 Dec 2023 | 100832315 | Citi Bank N.A. | ₹25 Cr | Open | |
| 11 Dec 2023 | 100837780 | Axis Bank Limited | ₹30 Cr | Open | |
| 10 Jul 2023 | 100754346 | Others | ₹20 Cr | Open |
To see the full charge records of Symbio Generrics India Private Limited, buy the company report.
Total charge records: 13 View all charges
Deals & funding
Symbio Generrics India Private Limited has 6 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹58.4 Lakh; the latest was in March 2022.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Acquisition | ₹100 Cr | Buyer: Ascent Capital Advisors India |
| Mar 2022 | Funding round · Series A | ₹52.1 Lakh | Investors: Aahi Family Trust, 3 individuals |
| Feb 2022 | Secondary share transfer | Undisclosed | Seller: an individual |
| Jan 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2019 | Rights issue | ₹36 Lakh | Investors: 4 individuals |
To see the full deal history of Symbio Generrics India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Symbio Generrics India Private Limited has 4 court cases on record: 3 filed by Symbio Generrics India, 1 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 2 |
| High courts | 1 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against Murli Krishna Pharma Private Limited | Pending |
| District court, South West, Delhi | Civil suit | Filed against the company by M/S Delius Pharmaceuticals Private Limited Through Its Director Mr Digvijay Kumar Shrivastawa | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed by the company against Murli Krishna Pharma Private Ltd | Disposed |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
To see the full case history of Symbio Generrics India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Symbio Generrics India Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 160 overdue payments to 17 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 17)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Hyma Synthesis Private Limited | |||
| an individual supplier | |||
| Robust Materials Technology Private Limited | |||
| Aic Enterprises Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Symbio Generrics India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Symbio Generrics India has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| VPL Chemicals Private Limited | U24100KA1999PTC025992 | |
| Copernicium Pharmaceuticals Private Limited | U24230KA2013PTC072419 |
To see the full group structure of Symbio Generrics India Private Limited, buy the company report.
Employees & EPFO
Symbio Generrics India Private Limited has a workforce of 161 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
GST
Symbio Generrics India has 6 GST registrations: 5 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAPCS9972B1ZO | Karnataka | Active | 10 May 2022 |
| 33AAPCS9972B2ZY | Tamil Nadu | Active | 01 Jul 2017 |
| 27AAPCS9972B1ZS | Maharashtra | Active | 16 Aug 2017 |
| 33AAZCS4288C1ZW | Tamil Nadu | Active | 07 Feb 2018 |
To see the full GST registrations and return filing status of Symbio Generrics India Private Limited, buy the company report.
Recent activity
Symbio Generrics India Private Limited has 10 board changes on record since 2011: 4 appointments and 6 cessations. The latest: Ajay Subhash Mittal ceased to be Nominee Director on 04 Dec 2024.
21 earlier events are in the company report.
Frequently asked questions
Symbio Generrics India is an active private limited company based in Bangalore, Karnataka, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 30 May 2011 (15+ years old) and is registered under CIN U74990KA2011PTC184231.
Symbio Generrics India has 4 current directors:
- Akash Suresh Puranik - Managing Director
- Salim Sadiq Shaikh - Whole-Time Director
- Kannan Natraj Sharma - Director
- Deepak Komaregowda - Nominee Director
The latest financial statements of Symbio Generrics India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Symbio Generrics India is 29AAPCS9972B1ZO, registered in Karnataka. The company has 6 GST registrations in all, of which 5 are active and 1 is cancelled or inactive. Other active GSTINs include 33AAPCS9972B2ZY (Tamil Nadu), 27AAPCS9972B1ZS (Maharashtra), 33AAZCS4288C1ZW (Tamil Nadu).
The CIN (Corporate Identification Number) of Symbio Generrics India is U74990KA2011PTC184231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Symbio Generrics India has 4 court cases on record: 3 filed by the company and 1 filed against it. 2 are pending. Most are in the district courts.
Symbio Generrics India was incorporated on 30 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Bangalore.
Symbio Generrics India has 6 deals on record (2 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹58.4 Lakh; the latest was in March 2022.
Ajay Subhash Mittal ceased to be Nominee Director on 04 Dec 2024. Kannan Natraj Sharma ceased to be Additional Director on 26 Sep 2022. Kannan Natraj Sharma was appointed as Director on 19 Sep 2022. Symbio Generrics India has 10 board changes on record in total.
Symbio Generrics India has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 160 overdue payments to 17 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Symbio Generrics India can be reached through the website symbiogenerics.com. Its registered office is in Bangalore, Karnataka, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
